Marcel C. G. van de Poll

Marcel C. G. van de Poll

Auto-generated profile, based on publicly available information

Marcel C. G. van de Poll

Department of Surgery Maastricht University Medical Center+ Maastricht University Maastricht the Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2023 in New England Journal of Medicine
Verified
Journal Article
Closed access
MSMartje M. Suverein
Martje M. Suverein
TDThijs S.R. Delnoij
Thijs S.R. Delnoij
RLRoberto Lorusso
Roberto Lorusso
GBGeorge J. Brandon Bravo Bruinsma
George J. Brandon Bravo Bruinsma
LOLuuk Otterspoor
Luuk Otterspoor
MPMarcel C.G. van de Poll
Marcel C.G. van de Poll
Extracorporeal cardiopulmonary resuscitation (CPR) restores perfusion and oxygenation in a patient who does not have spontaneous circulation. The evidence with regard to the effect of extracorporeal CPR on survival with a favorable neurologic outcome in refractory out-of-hospital cardiac arrest is inconclusive. In this multicenter, randomized, controlled trial conducted in the Netherlands, we assigned patients with an out-of-hospital cardiac arrest to receive extracorporeal CPR or conventional CPR (standard advanced cardiac life support). Eligible patients were between 18 and 70 years of age, had received bystander CPR, had an initial ventricular arrhythmia, and did not have a return of spontaneous circulation within 15 minutes after CPR had been initiated. The primary outcome was survival with a favorable neurologic outcome, defined as a Cerebral Performance Category score of 1 or 2 (range, 1 to 5, with higher scores indicating more severe disability) at 30 days. Analyses were performed on an intention-to-treat basis. Of the 160 patients who underwent randomization, 70 were assigned to receive extracorporeal CPR and 64 to receive conventional CPR; 26 patients who did not meet the inclusion criteria at hospital admission were excluded. At 30 days, 14 patients (20%) in the extracorporeal-CPR group were alive with a favorable neurologic outcome, as compared with 10 patients (16%) in the conventional-CPR group (odds ratio, 1.4; 95% confidence interval, 0.5 to 3.5; P = 0.52). The number of serious adverse events per patient was similar in the two groups. In patients with refractory out-of-hospital cardiac arrest, extracorporeal CPR and conventional CPR had similar effects on survival with a favorable neurologic outcome. (Funded by the Netherlands Organization for Health Research and Development and Maquet Cardiopulmonary [Getinge]; INCEPTION ClinicalTrials.gov number, NCT03101787.).

1 December 2009 in Clinical Nutrition
Verified
Journal Article
Closed access
JBJohanne G. Bloemen
Johanne G. Bloemen
KVKoen Venema
Koen Venema
MPMarcel C. van de Poll
Marcel C. van de Poll
SDSteven W. Olde Damink
Steven W. Olde Damink
WBWim A. Buurman
Wim A. Buurman
CDCornelis H. Dejong
Cornelis H. Dejong

1 May 2017 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
PMPaolo Meani
Paolo Meani
SGSandro Gelsomino
Sandro Gelsomino
ENEshan Natour
Eshan Natour
DJDaniel M Johnson
Daniel M Johnson
HRHans-Peter Brunner La Rocca
Hans-Peter Brunner La Rocca
RLRoberto Lorusso
Roberto Lorusso

1 February 2004 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
MPMarcel Cg van de Poll
Marcel Cg van de Poll
PSPeter B Soeters
Peter B Soeters
NDNicolaas Ep Deutz
Nicolaas Ep Deutz
KFKenneth Ch Fearon
Kenneth Ch Fearon
CDCornelis Hc Dejong
Cornelis Hc Dejong
The kidneys play a role in the synthesis and interorgan exchange of several amino acids. The quantitative importance of renal amino acid metabolism in the body is not, however, clear. We review here the role of the kidney in the interorgan exchange of amino acids, with emphasis on quantitative aspects. We reviewed relevant literature by using a computerized literature search (PubMed) and checking relevant references from the identified articles. Our own data are discussed in the context of the literature. The kidney takes up glutamine and metabolizes it to ammonia. This process is sensitive to pH and serves to maintain acid-base homeostasis and to excrete nitrogen. In this way, the metabolism of renal glutamine and ammonia is complementary to hepatic urea synthesis. Citrulline, derived from intestinal glutamine breakdown, is converted to arginine by the kidney. Renal phenylalanine uptake is followed by stoichiometric tyrosine release, and glycine uptake is accompanied by serine release. Certain administered oligopeptides (eg, glutamine dipeptides) are converted by the kidneys to their constituent components before they can be used in metabolic processes. The kidneys play an important role in the interorgan exchange of amino acids. Quantitatively, for several important amino acids, the kidneys are as important as the gut in intermediary metabolism. The kidneys may be crucial “mediators” of the beneficial effects of specialized, disease-specific feeding solutions such as those enriched in glutamine dipeptides.

1 June 2007 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
CDCornelis H. C. Dejong
Cornelis H. C. Dejong
MPMarcel C. G. van de Poll
Marcel C. G. van de Poll
PSPeter B. Soeters
Peter B. Soeters
RJRajiv Jalan
Rajiv Jalan
SDSteven W. M. Olde Damink
Steven W. M. Olde Damink
Liver failure is associated with hepatic encephalopathy (HE). An imbalance in plasma levels of aromatic amino acids (AAA) phenylalanine, tyrosine, and tryptophan and branched chain amino acids (BCAA) and their BCAA/AAA ratio has been suggested to play a causal role in HE by enhanced brain AAA uptake and subsequently disturbed neurotransmission. Until recently, data on this subject and the role of the liver and splanchnic bed were scarce, particularly in humans, due to inaccessibility of portal and hepatic veins. Here, we discuss, against a background of relevant literature, data obtained in patients undergoing liver resection or with a transjugular intrahepatic portasystemic stent shunt (TIPSS), where these veins are accessible. The BCAA/AAA ratio remained unchanged after major liver resection, but plasma AAA levels were inversely correlated (P < 0.001) with residual liver volume, in keeping with the observed hepatic AAA uptake. In patients with stable cirrhosis and a TIPSS, the plasma BCAA/AAA ratio was lower than in controls (1.19 ± 0.09 vs. controls: 3.63 ± 0.34). Gastrointestinal bleeding in cirrhotics with a TIPSS induced disturbances in BCAA levels and the BCAA/AAA ratio and induced catabolism, which could partly be corrected by isoleucine administration. AAA may be important in the pathogenesis of HE, but it is unlikely that they are the sole factors. HE most likely is a syndrome with multifactorial pathogenesis, where hyperammonemia, AAA/BCAA imbalances, inflammation, brain edema, and neurotransmitter changes interact. Novel therapies to normalize AAA levels in patients with liver failure (such as the molecular adsorbent recirculating system dialysis device) should probably be combined with supplementation of e.g. isoleucine and enhancing ammonia excretion by the kidneys.

15 August 2024 in The Lancet
Verified
Journal Article
Closed access
JBJulia L M Bels
Julia L M Bels
STSteven Thiessen
Steven Thiessen
RGRob J J van Gassel
Rob J J van Gassel
ABAlbertus Beishuizen
Albertus Beishuizen
ADAshley De Bie Dekker
Ashley De Bie Dekker
ADAdam Deane
Adam Deane